Capital Finance
According to financial services firm Jones Lang LaSalle, healthcare real estate investment trusts (HCREITs) have raised $22.5 billion over the past 18 months, spiking third party interest in the medical property sector.
Information technology and business process services firm CGI Group, Inc. announced this week that it will now report a separate health global vertical segment.
Web-based healthcare information provider HealthGrades announced Wednesday that it has reached a definitive agreement to merge with CPM, a customer relationship management solutions firm.
How can you make sure that the inventory ordered for provider encounters (DME, hearing aids, CPAP machines, ER trays, etc) are being accounted for on the patient’s bill? If you are not reconciling inventory with patient accounting, you are losing potential revenue.
Regenerative medicine company Stratatech Corp. has been awarded $4.6 million by the National Institute of Diabetes and Digestive and Kidney Diseases. The grant will fund the first human clinical trial of Stratatech's ExpressGraft antimicrobial skin substitute, a potential treatment for chronic diabetic foot ulcers.
Grants totaling $4.5 million have been awarded by the Agency for Healthcare Research and Quality (AHRQ) to support three research centers that focus on clinical preventive services.
How did Michigan hospitals save over 2,000 lives as well as $300 million dollars? They implemented a pioneering, patient care program to increase safety, quality and efficiency.
Medical technology manufacturer C. R. Bard Inc. announced Wednesday that it reached a definitive agreement to acquire Medivance Inc. for approximately $250 million.
Analytix On Demand (AOD), a provider of software-as-a-service business intelligence solutions for healthcare, announced Tuesday that it has acquired Integrated Revenue Management, Inc. (IRM), a national healthcare consulting and education company with a focus on revenue cycle management. The newly created company headquartered in Irvine, Calif., will be called CentraMed.
Venture capital investment in New England dropped 45 percent in the most recent quarter, largely due to fewer deals in biotechnology and medical devices. The national trend is down, too, though not as much, according to a new report from the National Venture Capital Association and PricewaterhouseCoopers.